Moreover, F. nucleatum-positive CRC tumours show resistance to the chemotherapeutic drug oxaliplatin because F. nucleatum promotes the survival and proliferation of CRC cells via Toll-like receptor 4 (TLR-4)-mediated induction of autophagy in those cells [80,81,82]. This evidence concerns the gene TLR4 and neoplasm.